Menopause

Primary Care - Clinics in Office Practice

Volumn 36, Issue 1, 2009, Pages 199-226

  Weismiller, David G ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Climacteric; Hormone therapy; Menopause; Perimenopause; Postmenopausal bleeding; Vasomotor symptoms

Indexed keywords

ALENDRONIC ACID; ALPHA TOCOPHEROL; CALCITONIN; CLONIDINE; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTRADIOL PLUS LEVONORGESTREL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; ETIDRONIC ACID; FEMRING; FLUOXETINE; FOLLITROPIN; GABAPENTIN; IBANDRONIC ACID; INHIBIN A; INHIBIN B; ISOFLAVONE DERIVATIVE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; PAMIDRONIC ACID; PARATHYROID HORMONE[1-34]; PAROXETINE; PHYTOESTROGEN; PROGESTERONE; RALOXIFENE; RISEDRONIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; ZOLEDRONIC ACID;

ABDOMINAL PAIN; ANGELICA SINENSIS; ANXIETY; APPETITE; ARTHRALGIA; ASTHENIA; AUTOIMMUNE HEPATITIS; BACKACHE; BLOOD PRESSURE MONITORING; BREAST CANCER; BREAST SELF EXAMINATION; BREAST TENDERNESS; CANCER SCREENING; CIMICIFUGA RACEMOSA; CLIMACTERIUM; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONSTIPATION; DEPRESSION; DIARRHEA; DIZZINESS; DROWSINESS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; EVENING PRIMROSE; FATIGUE; FOLLITROPIN BLOOD LEVEL; FRACTURE; GASTROINTESTINAL SYMPTOM; GINSENG; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOTENSION; INFLUENZA VACCINATION; INSOMNIA; LIBIDO; MASTALGIA; MENOPAUSAL SYNDROME; MENOPAUSE; MENTAL INSTABILITY; MYALGIA; NIGHT SWEAT; ORTHOSTATIC HYPOTENSION; OSTEOPOROSIS; OVARY CANCER; PAPANICOLAOU TEST; PATIENT COUNSELING; PHOTOSENSITIZATION; PREMENSTRUAL SYNDROME; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RASH; RED CLOVER; REVIEW; RISK ASSESSMENT; SEDATION; SEIZURE THRESHOLD; SELF EVALUATION; SEXUALITY; SIDE EFFECT; SIGMOIDOSCOPY; SKIN MANIFESTATION; SLEEP DISORDER; SOMNOLENCE; TREATMENT CONTRAINDICATION; URINARY TRACT INFECTION; URINE INCONTINENCE; UTERINE CERVIX CANCER; UTERUS BLEEDING; VAGINAL DRYNESS; VOMITING; WEIGHT GAIN; XEROSTOMIA;

AGE FACTORS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MASS SCREENING; PERIMENOPAUSE; POSTMENOPAUSE; RISK FACTORS; VASOMOTOR SYSTEM; WOMEN'S HEALTH;

EID: 60349115996     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2008.10.007     Document Type: Review

References (134)

1. Hargrove J.T., and Eisenberg E. Menopause. Med Clin North Am 79 (1995) 1337-1356
2. Mitchell E., Woods N., and Mariella A. Three stages of the menopausal transition: observations from the Seattle Midlife Women's Health Study. Menopause 7 (2000) 334-349
3. Soules M.R., Sherman S., Parrott E., et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76 (2001) 874-878
4. McKinlay S.M. The normal menopause transition: an overview. Maturitas 23 (1996) 137-145
5. Willett W., Stampfer M.J., Bain C., et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol 117 (1983) 651-658
6. Kaufman D.W., Slone D., Rosenberg L., et al. Cigarette smoking and age at natural menopause. Am J Public Health 72 (1980) 420-422
7. Brambilla D.J., and McKinlay S.M. A prospective study of factors affecting age at menopause. J Clin Epidemiol 42 (1989) 1031-1039
8. Bromberger JT, Matthews KA, Kuller LH, et al. Prospective study of determinants of age at menopause, Am J Epidemiol 1997;145:124-133.
9. Hiatt R.A., and Fireman B.H. Smoking, menopause, and breast cancer. J Natl Cancer Inst 76 (1986) 833-838
10. Adena M.A., and Gallagher H.G. Cigarette smoking and the age at menopause. Ann Hum Biol 9 (1982) 121-130
11. Gold E.B., Bromberger J., Crawford S., et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 153 (2001) 865-874
12. Coulam C.B., Anderson S.C., and Annegers J.F. Incidence of premature ovarian failure. Obstet Gynecol 67 (1986) 604-606
13. Gold E.B., Block G., Crawford S., et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation (SWAN). Am J Epidemiol 159 12 (2004) 1189-1199
14. Mold J.W., Mathew M.K., Belgore S., et al. Prevalence of night sweats in primary care patients: an OKPRN and TAFP - Net collaborative study. J Fam Pract 51 (2002) 452-456
15. O'Connor KA, Holman DJ, Wood JW. Menstrual cycle variability and the perimenopause. Am J Human Biol 2001;13:465-78.
16. Strauss S.S., and Clarke B.A. Adolescence. In: Lewis J.A., and Berstein J. (Eds). Women's Health: a relational perspective across the life cycle (1996), Jones and Bartlett, Sudbury (MA) 65-106
17. Gorril M.J., and Marshall J.R. Pharmacology of estrogen and estrogen induced effects on non-reproductive organs and systems. J reprod Med 31 Suppl (1986) 842-847
18. Ingegno M.D., Money S.R., Thelmo W., et al. Progesterone receptors in the human heart and great vessels. Lab Invest 59 (1988) 353-356
19. Wren B.G. The menopause and society. In: Wren B.G., and Nachtigall L.E. (Eds). Clinical management of the menopause (1986), McGraw-Hill Book Company, Sydney, Australia 1-6
20. Munster K., Schmidt L., and Helm P. Length and variation in the menstrual cycle-a cross-sectional study from a Danish country. Br J Obstet Gynaecol 99 (1992) 422-429
21. Treloar A.E., Boynton R.E., Behn B.G., et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil 12 (1967) 77-126
22. Vollmann R.F. The menstrual cycle. In: Friedman E.A. (Ed). Major problems in obstetrics and gynecology (1977), WB Saunders, Philadelphia 73-158
23. MacNaughton J., Banah M., McCloud P., et al. Age-related changes in life follicle stimulating hormone, oestradiol and immunoreactive inhibin in women of reproductive age. Clin Endocrinol 36 (1992) 339-345
24. McKinlay S.M., Brambilla D.J., and Posner J.G. The normal menopause transition. Maturitas 4 (1992) 103-105
25. Meldrum D.R. Female reproductive aging-ovarian and uterine factors. Fertil Steril 59 (1993) 1-7
26. Jansen R.P. Fertility in older women. International Planned Parenthood Foundation Med Bull 18 (1984) 1624-1626
27. Menken J., Trussell J., and Larsen U. Age and infertility. Science 233 (1986) 1389-1394
28. van Noord-Zaadstra B.M., Looman C.W.N., Alsbach H., et al. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ 302 (1991) 1361-1365
29. Byyny R.L., and Speroff L. A clinical guide for the care of older women: primary and preventive care. 2nd Edition (1996), Lippincott, Williams & Wilkins, Baltimore (MD)
30. Eden J.A. Androgenic disorders and the menopause. In: Wren B.G., and Nachtigall L.E. (Eds). Clinical management of the menopause (1996), McGraw-Hill Company, Sydney Australia 32-40
31. Speroff L., Glass R.H., and Kase N.G. Menopause and postmenopausal hormone therapy. In:. Clinical gynecologic endocrinology and infertility. 6th Edition (1999), Lippincott, Williams & Wilkins, Baltimore (MD) p. 643-780
32. Longcope C., Jaffee W., and Griffling G. Production rates of androgens and oestrogens in postmenopausal women. Maturitas 3 (1981) 215-223
33. Hunter M.S., and Liao K.L. Determinants of treatment choice for menopausal hot flashes: hormonal versus psychological versus no treatment. J Psychosom Obstet Gynaecol 16 (1995) 101-108
34. Hardy R., and Kuh D. Change in psychological and vasomotor symptom reporting during the menopause. Soc Sci Med 55 (2002) 1975-1988
35. Kaufert P.A., Gilbert P., and Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas 14 (1992) 143-155
36. Jacobs Institute of Women's Health Expert Panel on Menopause Counseling. Guidelines for counseling women on the management of menopause. Washington (DC): Jacobs Institute of Women's Health; 2000.
37. AACE Menopause Guidelines Revision Task Force. American Association of Clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract 12 (2006) 315-337
38. Bastian L.A., Smith C.M., and Nanda K. Is this woman perimenopausal?. JAMA 289 (2003) 895-902
39. Harlow S.D., Crawford S.L., Sommer B., et al. Self-defined menopausal status in a multi-ethnic sample of midlife women. Maturitas 36 (2000) 93-112
40. Garamszegi C., Dennerstein L., Dudley E., et al. Menopausal status: subjectively and objectively defined. J Psychosom Obstet Gynaecol 19 (1998) 165-173
41. Jinping X., Bartoces M., Neale V.A., et al. Natural history of menopause symptoms in primary care patients:a MetroNet study. J Am Board Fam Pract 18 (2005) 374-382
42. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 593 (1990) 52-86
43. Avis N.E., Stellato R., Crawford S., et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 52 (2001) 345-356
44. Wylie_rosett J. Menopause, micronutrients, and hormone therapy. Am J Clin Nutr 81 (2005) 1223S-1231S
45. Li C., Samsioe G., Borgfeldt J., et al. what are the background factors? A prospective population-based cohort study of Swedish women (The Women's Health in Lund Area study). Am J Obstet Gynecol 189 (2003) 1646-1653
46. Greendale G.A., and Gold E.B. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?. Am J Med 118 Suppl 2 (2005) 148-154
47. Grady D., and Sawaya G.F. Discontinuation of postmenopausal hormone therapy. Am J Med 118 Suppl 2 (2005) 163-165
48. Nelson H.D., Vesco K.K., Haney E., et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295 (2006) 2057-2071
49. MacLennan A., Lester S., and Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a scientific review. Climacteric 4 (2001) 58-74
50. Nelson H.D. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 291 (2004) 1610-1620
51. Ettinger B. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage. Am J Med 118 Suppl 2 (2005) 74-78
52. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
53. Tice J.A., and Grady D. Alternatives to estrogens for treatment of hot flashes-are they effective and safe?. JAMA 295 (2006) 2076-2078
54. Tang G.W. The climacteric of Chinese factory workers. Maturitas 19 (1994) 177-182
55. Freedman R.R. Physiology of hot flashes. Am J Human Biol 13 (2001) 453-464
56. Rekers H., Drogendijk A.C., Valkenburg H.A., et al. The menopause, urinary incontinence and other symptoms of the genitor-urinary tract. Maturitas 15 (1992) 101-111
57. Kuh D., Cardozo L., and Hardy R. Urinary incontinence in middle aged women: childhood enuresis and other lifetime risks factors in a British prospective cohort. J Epidemiol Community Health 53 (1999) 453-458
58. Greendale G.A., Lee N.P., and Arriola E.R. The menopause. Lancet 343 (1999) 571-580
59. Milsom I., Ekelund P., Molander U., et al. The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women. J Urol 149 (1993) 1459-1462
60. Sherburn M., Guthrie J.R., Dudley E.C., et al. Is incontinence associated with menopause?. Obstet Gynecol 98 (2001) 628-633
61. Herjanic B., and Reich W. Development of a structured psychiatry interview for children: agreement between child and parent on individual symptoms. J Abnorm Child Psychol 10 (1982) 307-324
62. Halbreich U. Gonadal hormones and antihormones, serotonin and mood. Psychopharmacol Bull 26 (1990) 291-295
63. Pearlstein T.B., Frank E., Rivera-Tovar A., et al. Prevalence of axis II and axis III disorder s in women with late luteal phase dysphoric disorder. J Affect Disord 20 (1990) 129-134
64. Bancroft J., and Sartorius N. The effects of oral contraceptives on the well being and sexuality of women. Oxford Review of Reproductive Biology 12 (1990) 57-92
65. McCormick L.H. Depression in mothers of children with attention deficit hyperactivity disorder. Fam Med 27 (1995) 176-179
66. Yonkers K.A., and Austin L.S. Mood disorders: women and affective disorders. Prim Psychiatry 3 (1996) 27-28
67. Leibenluft E. Women with bipolar illness: clinical and research issues. Am J Psychiatry 153 (1996) 163-173
68. Parry B.L. Reproductive factors affecting the course of affective illness in women. Psychiatr Clin North Am 12 (1989) 207-220
69. Hallstrom T., and Samuelson S. Mental health in the climacteric. The longitudinal study of women in Gothenburg. Acta Obstet Gynecol Scand Suppl 130 (1985) 13-18
70. Holte A., and Mikkelsen A. Psychosocial determinants of climacteric complaints. Maturitas 13 (1991) 205-215
71. Matthews K.A., Wing R.R., Kuller L.H., et al. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J Consult Clin Psychol 58 (1990) 345-351
72. Cawood E.H.H., and Bancroft J. Steroid hormones, the menopause, sexuality and well being of women. Psychol Med 26 (1996) 925-936
73. Gath D., Osborn M., Bungay G., et al. Psychiatric disorder and gynecological symptoms in middle-aged women: A community survey. BMJ 294 (1987) 213-218
74. Porter M., Penney G.C., Russell D., et al. A population based survey of women's experience of the menopause. Br J Obstet Gynaecol 103 (1996) 1025-1028
75. Torgerson D.J., Thomas R.E., and Reid D.M. Mothers and daughters menopausal ages, is there a link. Eur J Obstet Gynecol Reprod Biol 74 (1997) 63-66
76. Garnett T., Studd J.W.W., Henderson A., et al. Hormone implants and tachyphylaxis. Br J Obstet Gynaecol 97 (1990) 917-921
77. Hay A.G., Bancroft J., and Johnstone E.C. Affective symptoms in women attending a menopause clinic. Br J Psychiatry 164 (1994) 513-516
78. Hee J., MacNaughton J., Bangah M., et al. Perimenopausal patterns of gonadotrophins, immunoreactive inhibin, oestradiol and progesterone. Maturitas 18 (1993) 9-20
79. Sherman B.M., and Korenman S.G. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 55 (1975) 699-706
80. Burger H.G., Cahir N., Robertson D.M., et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Ecdocrinol Metab. 73 (1991) 667-673
81. Illingworth P.J., Reddi K., Smith K.B., et al. The source of inhibin secretion during the human menstrual cycle. J Clin Endocrinol Metab 73 (1991) 667-673
82. ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 107 (2006) 1453-1472
83. Peterson H.B., and Curtis K.M. Long-acting methods of contraception. N Engl J Med 353 (2005) 2169-2175
84. Medical eligibility criteria for contraceptive use. 3rd Edition. (2004), World Health Organization, Geneva
85. Sarrell P.M., and Whotehead M.I. Sex and menopause: defining the issues. Maturitas 7 (1985) 217-224
86. Robertson R. Sexuality and the menopause. In: Wren B.G., and Nachtigall L.E. (Eds). Clinical management of the menopause (1996), McGraw Hill Book Company, Sydney, Australia 41-48
87. Bachmann G.A., and Leiblum S.R. Sexuality in sexagenarian women. Maturitas 3 (1991) 43-50
88. Avis N.E., Stellato R., Crawford S., et al. Is there an association between menopause status and sexual functioning?. Menopause 7 (2000) 297-309
89. Koster A., and Garde K. Sexual desire and menopausal development: a prospective study of Danish women born in 1936. Maturitas 16 (1993) 49-60
90. Pfister S., and Dougherty P. Growing older. In: Lewis J.A., and Bernstein J. (Eds). Women's health: a relational perspective across the life cycle (1996), Jones and Bartlett, Sudbury (MA) 192-236
91. Newman G., and Nichols C.R. Sexual activities and attitudes in older persons. JAMA 173 (1960) 335-341
92. MacLennan A., Lester A., and Moore V. Oral estrogen replacement therapy versus placebo for hot flushes [Cochrane Review on CD-ROM] (2002), Cochrane Library, Oxford, England Update Software
93. Hing E., and Brett K.M. Changes in US prescribing patterns of menopausal hormone therapy. 2001-2003. Obstet Gynecol 108 (2006) 33-40
94. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280 7 (1998) 605-613
95. Million Women Study Collaborators T. The Million Women Study: a confidential national study of women's health. Available at:. http://www.millionwomenstudy.org/index2.html Accessed May 6, 2008
96. The Nurses' Health Study. Available at:. http://www.channing.harvard.edu/nhs/?fb_page_id=6548964549& Accessed August 1, 2008
97. Nelson H.D., Humphrey L.L., LeBlanc E., et al. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions. Summary of the evidence for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality. Available at:. http://www.ahrq.gov/clinic/3rduspstf/hrt/hrtsum1.htm Accessed August 1, 2008
98. North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 14 (2007) 168-182
99. Institute for Clinical Systems Improvement. Health care guideline: menopause and hormone therapy (HT): collaborative decision-making and management. Available at:. http://www.icsi.org/guidelines_and_more/gl_os_prot/womens_health/menopau se_and_hormone_therapy/menopause_and_hormone_therapy_ht_collaborative_de cision-making_and_management_.html Accessed May 29, 2008
100. Greendale G.A., Reboussin B.A., Hogan P., et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 92 (1998) 982-988
101. Kelley C. Estrogen and its effect on vaginal atrophy in post menopausal women. Urol Nurs 27 1 (2007) 40-45
102. Raz R., and Stamm W.E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329 (1993) 753-756
103. Newton K.M., Buist D.S., Keenan N.L., et al. Use of alternative therapies for menopause symptoms: results of a population-based survey [erratum appears in Obstet Gynecol]. Obstet Gynecol 100 (2002) 18-25
104. Cheema D., Coomarasamy A., and El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structures evidence-based review. Arch Gynecol Obstet 276 (2007) 463-469
105. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause society. Menopause 11 (2004) 11-33
106. Bachmann G.A. The hypoandrogenic woman: pathophysiologic overview. Fertil Steril 77 Suppl 4 (2002) S72-S75
107. Adashi E.Y. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland [erratum in Fertil Steril. 1995; 63:684]. Fertil Steril 62 (1994) 20-27
108. Braunstein G.D. Androgen insufficiency in women: summary of critical issues. Fertil Steril 77 Suppl 4 (2002) S94-S99
109. Bachmann G., Bancroft J., and Braunstein(Princeton) G. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 77 Suppl 4 (2002) 660-665
110. Sherwin B.B., Gelfand M.M., and Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 47 (1985) 339-351
111. Davis S.R., McCloud P., Strauss B.J., et al. Testosterone enhances estradiol effects on postmenopausal bone density and sexuality. Maturitas 21 (1995) 227-236
112. Sarrel P., Dobay B., and Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy: sexual behavior and neuroendocrine responses. J Reprod Med 43 (1998) 847-856
113. Dobs A.S., Nguyen T., Pace C., et al. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in post menopausal women. J Clin Endocrinol Metab 87 (2002) 1509-1516
114. Shifren J.L., Braunstein G.D., Simon J.A., et al. Transdermal testosterone treatment in women with imparired sexual function after oophorectomu. N Engl J Med 343 (2000) 682-688
115. Watts N.B., Notelovitz M., Timmons M.C., et al. Comparison of oral estrogens and estrogen plus androgen on bone mineral density, menopause symptoms and lipid-lipoprotein profiles in surgical menopause [erratum in Obstet Gynecol. 1995;85(5 Pt 1):668]. Obstet Gynecol 85 (1995) 529-537
116. Raisz L.G., Wiita B., Artis A., et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 81 (1996) 37-43
117. Need A.G., Durbridge T.C., and Nordin B.E. Anabolic steroids in postmenopausal osteoporosis. Wien Med Wochenschr 143 (1993) 392-395
118. Hassager C., Riis B.J., Podenphant J., et al. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal. Maturitas 11 (1989) 305-317
119. Tariq S., Kamel H., and Morley J. Dehydroepiandrosterone and pregnenolone. In: Meilke A.W. (Ed). Endocrine replacement therapy in clinical practice (2003), Humana Press, Totowa (NJ) 307-329
120. Tinetti M.E., Inouye S.K., Gill T.M., et al. Shard risk for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 273 17 (1995) 1348-1353
121. Vogel VG, Costantino JP, Wickerman DLO, et al. Effects of tamoxifen vs Raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295(23):2727-41.
122. Heiss G., Wallace R., Anderson G.L., et al. for the WHI Investigators. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 299 9 (2008) 1036-1045
123. Ben-Yehuda O.M., Kim Y.B., and Leuchter R.S. Does hysteroscopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasis or carcinoma?. Gynecol Oncol 68 (1998) 4-7
124. Tabor A., Watt H.C., and Wald N.J. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 99 (2002) 663-670
125. Feldman S., Berkowitz R.S., and Tosteson A.N.A. Cost-effectiveness of strategies to evaluate postmenopausal bleeding. Obstet Gynecol 81 (1993) 968-975
126. Gimpelson R.J. Panoramic hysteroscopy with directed biopsies vs. dilatation and curettage for accurate diagnosis. J Reprod Med 29 (1984) 575-578
127. Krampl E., Bourne T., Hurlen-Solbakken H., et al. Transvaginal ultrasonography, sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding. Acta Obstet Gynecol Scand 80 (2001) 616-622
128. O'Connell L.P., Fries M.H., Zeringue E., et al. Triage of abnormal postmenopausal bleeding: a comparison of endometrial biopsy and transvaginal sonohysterography versus fractional curettage with hysteroscopy. Am J Obstet Gynecol 178 (1998) 956-961
129. Mihm L.M., Quick V.A., Brumfield J.A., et al. The accuracy of endometrial biopsy and saline sosohysterography in the determination of the cause of abnormal uterine bleeding. Am J Obstet Gynecol 186 (2002) 858-860
130. Stovall T.G., Ling F.W., and Morgan P.L. A perspective, randomized comparison of the Pipelle endometrial sampling device with the Novak curette. Am J Obstet Gynecol 165 5 pt 1 (1991) 1287-1290
131. Grimes D.A. Diagnostic dilation and curettage: a reappraisal. Am J Obstet Gynecol 142 (1982) 1-6
132. Ong S., Duffy T., Lenehan P., et al. Endometrial pipelle biopsy compared to conventional dilatation and curettage. Ir J Med Sci 166 (1997) 47-49
133. Tahir M.M., Bigrigg M.A., Brookers S.T., et al. A randomized controlled trial comparing transvaginal ultrasound, outpatient hysteroscopy and endometrial biopsy with impatient hysteroscopy and curettage. Br J Obstet Gynaecol 106 (1999) 1259-1264
134. Goldenberg N.M., Wang P., Glueck C.J., et al. An observational study of sever hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta 332 (2003) 11-19